EP0902288A3 - Diagnose de blessures par la quantification de cortisol dans les fluides de blessures - Google Patents

Diagnose de blessures par la quantification de cortisol dans les fluides de blessures Download PDF

Info

Publication number
EP0902288A3
EP0902288A3 EP98307357A EP98307357A EP0902288A3 EP 0902288 A3 EP0902288 A3 EP 0902288A3 EP 98307357 A EP98307357 A EP 98307357A EP 98307357 A EP98307357 A EP 98307357A EP 0902288 A3 EP0902288 A3 EP 0902288A3
Authority
EP
European Patent Office
Prior art keywords
wound
diagnosis
fluids
cortisol
quantitating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP98307357A
Other languages
German (de)
English (en)
Other versions
EP0902288A2 (fr
Inventor
Tyrone C. Hutchinson
Hansen P. Swaniker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ethicon Inc
Original Assignee
Ethicon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethicon Inc filed Critical Ethicon Inc
Publication of EP0902288A2 publication Critical patent/EP0902288A2/fr
Publication of EP0902288A3 publication Critical patent/EP0902288A3/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/743Steroid hormones
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/815Test for named compound or class of compounds
    • Y10S436/817Steroids or hormones
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/20Oxygen containing
    • Y10T436/203332Hydroxyl containing

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
EP98307357A 1997-09-12 1998-09-11 Diagnose de blessures par la quantification de cortisol dans les fluides de blessures Withdrawn EP0902288A3 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/928,541 US5912114A (en) 1997-09-12 1997-09-12 Wound diagnosis by quantitating cortisol in wound fluids
US928541 1997-09-12

Publications (2)

Publication Number Publication Date
EP0902288A2 EP0902288A2 (fr) 1999-03-17
EP0902288A3 true EP0902288A3 (fr) 2000-07-19

Family

ID=25456388

Family Applications (1)

Application Number Title Priority Date Filing Date
EP98307357A Withdrawn EP0902288A3 (fr) 1997-09-12 1998-09-11 Diagnose de blessures par la quantification de cortisol dans les fluides de blessures

Country Status (4)

Country Link
US (1) US5912114A (fr)
EP (1) EP0902288A3 (fr)
JP (1) JPH11190736A (fr)
CA (1) CA2247280A1 (fr)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2283597C (fr) * 1998-10-02 2008-02-05 Ortho-Clinical Diagnostics, Inc. Conjugats de cortisol reduit
US6312663B1 (en) 1999-03-19 2001-11-06 Joseph V. Boykin, Jr. Prediction of diabetes impaired wound healing by urinary nitrate assay
GB2381452B (en) * 2001-11-05 2005-08-10 Johnson & Johnson Medical Ltd Wound monitoring
US20030134332A1 (en) * 2001-11-28 2003-07-17 Boykin Joseph V. Diagnosis of endothelial dysfunction by nitric oxide bioactivity index
GB2390157B (en) * 2002-06-25 2005-09-28 Johnson & Johnson Medical Ltd Wound fluid collecting and indicating device
US6983177B2 (en) * 2003-01-06 2006-01-03 Optiscan Biomedical Corporation Layered spectroscopic sample element with microporous membrane
US20040131088A1 (en) * 2003-01-08 2004-07-08 Adtran, Inc. Shared T1/E1 signaling bit processor
US8460243B2 (en) 2003-06-10 2013-06-11 Abbott Diabetes Care Inc. Glucose measuring module and insulin pump combination
US7722536B2 (en) 2003-07-15 2010-05-25 Abbott Diabetes Care Inc. Glucose measuring device integrated into a holster for a personal area network device
US20050170445A1 (en) * 2004-01-07 2005-08-04 Duke University Methods of establishing profiles for use in evaluating wound healing and biocompatibility of implant materials and microarrays useful therefor
WO2005119524A2 (fr) 2004-06-04 2005-12-15 Therasense, Inc. Architecture hote-client de soins pour le diabete et systemes de gestion de donnees
GB2430029B (en) * 2005-09-07 2009-04-01 Ethicon Inc Diagnostic markers of wound infection II
AU2007275301A1 (en) * 2006-07-20 2008-01-24 Amgen Inc. Substituted azole aromatic heterocycles as inhibitors of 11-beta-HSD-1
US20080060550A1 (en) * 2006-09-12 2008-03-13 Macdonald Gavin Color changing skin sealant with co-acid trigger
US20080063615A1 (en) * 2006-09-12 2008-03-13 Macdonald John Gavin Color changing skin sealant
US20080145316A1 (en) * 2006-12-14 2008-06-19 Macdonald John Gavin Skin coating with microbial indicator
CA2692128A1 (fr) 2007-06-21 2008-12-31 Amgen Inc. Procede servant a fabriquer des 2-aminothiazolones substituees
US20090123569A1 (en) * 2007-11-08 2009-05-14 Macdonald John Gavin Coverage indicating technology for skin sealants using tannates
EP2291370B1 (fr) 2008-05-01 2013-11-27 Vitae Pharmaceuticals, Inc. Inhibiteurs cycliques de la 11-bêta-hydroxystéroïde déhydrogénase 1
NZ590495A (en) 2008-07-25 2012-10-26 Vitae Pharmaceuticals Inc Dihydropyridin-phenyl-3-oxazinan-2-ones as inhibitors of 11beta-hydroxysteroid dehydrogenase 1
WO2010010157A2 (fr) 2008-07-25 2010-01-28 Boehringer Ingelheim International Gmbh Inhibiteurs de la 11 bêta-hydroxystéroïde déshydrogénase 1
JP5679997B2 (ja) 2009-02-04 2015-03-04 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 11β−ヒドロキシステロイドデヒドロゲナーゼ1の環状阻害剤
CA2750517A1 (fr) 2009-02-04 2010-08-12 Vitae Pharmaceuticals, Inc. Inhibiteurs cycliques de 11 beta-hydroxysteroide deshydrogenase 1
WO2010124277A2 (fr) * 2009-04-24 2010-10-28 University Of Florida Research Foundation Inc. Matériaux et procédés pour déterminer et cartographier les microbes et biofilms microbiens sur les lésions
AR076936A1 (es) 2009-06-02 2011-07-20 Vitae Pharmaceuticals Inc Inhibidores de carbamato y urea de la 11 beta hidroxiesteroide deshidrogenasa 1
US8927539B2 (en) 2009-06-11 2015-01-06 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1 based on the 1,3-oxazinan-2-one structure
EP2448928B1 (fr) 2009-07-01 2014-08-13 Vitae Pharmaceuticals, Inc. Inhibiteurs cycliques de la 11-bêta-hydroxystéroïde déshydrogénase 1
US9135693B2 (en) * 2010-05-18 2015-09-15 Skin Of Mine Dot Com, Llc Image calibration and analysis
WO2011159760A1 (fr) 2010-06-16 2011-12-22 Vitae Pharmaceuticals, Inc. Hétérocycles à 5, 6 et 7 chaînons substitués, médicaments contenant ces composés et leur utilisation
US10136845B2 (en) 2011-02-28 2018-11-27 Abbott Diabetes Care Inc. Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same
US9084530B2 (en) 2012-04-12 2015-07-21 Elwha Llc Computational methods and systems for reporting information regarding appurtenances to wound dressings
US10130518B2 (en) 2012-04-12 2018-11-20 Elwha Llc Appurtenances including sensors for reporting information regarding wound dressings
US9024751B2 (en) 2012-04-12 2015-05-05 Elwha Llc Dormant to active appurtenances for reporting information regarding wound dressings
US10226212B2 (en) 2012-04-12 2019-03-12 Elwha Llc Appurtenances to cavity wound dressings
US10265219B2 (en) 2012-04-12 2019-04-23 Elwha Llc Wound dressing monitoring systems including appurtenances for wound dressings
US10158928B2 (en) 2012-04-12 2018-12-18 Elwha Llc Appurtenances for reporting information regarding wound dressings
MX2017004520A (es) 2014-10-14 2018-03-15 Lynch Samuel Composiciones para tratar heridas.
WO2016061590A1 (fr) 2014-10-17 2016-04-21 Wardell Mark R Procédé de détection de protéases et d'infection active dans des fluides biologiques et des tissus
US10444213B2 (en) 2016-08-25 2019-10-15 Viavi Solutions Inc. Spectroscopic classification of conformance with dietary restrictions
WO2020027192A1 (fr) * 2018-07-31 2020-02-06 サラヤ株式会社 Kit de réactif permettant la détection d'un biofilm et méthode de détection de biofilm
WO2023247792A1 (fr) 2022-06-24 2023-12-28 Trauma Care Consult Traumatologische Forschung Gemeinnützige Gesellschaft Mbh Méthode de diagnostic de plaies

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4128629A (en) * 1977-07-05 1978-12-05 Corning Glass Works Extraction-free cortisol assay
DE4314493A1 (de) * 1993-05-03 1994-11-10 Peter Prof Dr Rohdewald Verfahren und Teststreifen zur Bestimmung eines Analyten
EP0733903A1 (fr) * 1995-03-24 1996-09-25 Société Anonyme dite: IMMUNOTECH S.A. Procédé de dosage immunologique du cortisol, notamment urinaire, et réactifs utilisés

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4128629A (en) * 1977-07-05 1978-12-05 Corning Glass Works Extraction-free cortisol assay
DE4314493A1 (de) * 1993-05-03 1994-11-10 Peter Prof Dr Rohdewald Verfahren und Teststreifen zur Bestimmung eines Analyten
EP0733903A1 (fr) * 1995-03-24 1996-09-25 Société Anonyme dite: IMMUNOTECH S.A. Procédé de dosage immunologique du cortisol, notamment urinaire, et réactifs utilisés

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
ENWONWU C O; SAWIRIS P; CHANAUD N: "Effect of Marginal ascorbic acid deficiency on saliva level of cortisol in the guinea pig", ARCHIVES OF ORAL BIOLOGY, vol. 40, no. 8, August 1995 (1995-08-01), pages 737 - 742, XP000886885 *
ENWONWU CYRIL O; MEEKS VALLI I; SAWIRIS PETER G: "Elevated Cortisol levels in Whole saliva in HIV infected individuals", EUROPEAN JOURNAL OF ORAL SCIENCES, vol. 104, 1996, pages 322 - 324, XP000886865 *
HOWSER R L ET AL: "What you need to know about corticosteroid therapy", AMERICAN JOURNAL OF NURS., vol. 95, no. 8, August 1995 (1995-08-01), pages 44 - 48, XP000886929 *
S W MBUGUA; L A SKOGLUND; O DJOSELAND AND P LOKKEN: "Adrenicortical suppression by a glucocorticoid effect of a single i.m. injection of betamethasone depot versus placcebo given prior to orthopaedic surgery in Dogs", ACTA VETERINARIA SCANDINAVICA, vol. 29, 1988, pages 415 - 420, XP000886864 *

Also Published As

Publication number Publication date
EP0902288A2 (fr) 1999-03-17
US5912114A (en) 1999-06-15
JPH11190736A (ja) 1999-07-13
CA2247280A1 (fr) 1999-03-12

Similar Documents

Publication Publication Date Title
EP0902288A3 (fr) Diagnose de blessures par la quantification de cortisol dans les fluides de blessures
ATE264507T1 (de) Visuell lesbarer reagenzteststreifen
EE9700163A (et) Diagnostiline testkandja, selle kasutamine ja meetod vedeliku analüüdi määramiseks
CA2286680A1 (fr) Dispositif d'analyse a element detachable
NO951722D0 (no) Fluid for anvendelse i en oljebrönn
NO20002844D0 (no) Forbedret elektrokjemisk biosensorteststrimmel
IL149665A0 (en) Reagent test strip for analyte determination
AU6085996A (en) Direct-reading reagent test strip
ZA959853B (en) Lubricating composition including an ester - use of the composition and well fluid including the composition.
DE69510685D1 (de) Topographiemessung von schlämmen in öltanks
DE69715430D1 (de) Hydrodynamische schmiermitteldichtung für niedrige drehmomente
AU2002324881A1 (en) Diagnostic and prognostic tests
CA2379135A1 (fr) Test de l'age et de l'etat du liquide de frein
GB2335742B (en) Fluid pressure testing
CA2284199A1 (fr) Procede servant a mesurer le taux d'anions de carboxylate dans un liquide de refroidissement de moteur et ensemble test permettant de mettre en oeuvre le procede
DE59712951D1 (de) Dichtelement für messfühler
GB2339281B (en) Test strip for the immunochemical detection of substances
DE69804047D1 (de) Drehmomentprüfer für Lager
CA2068643A1 (fr) Laminage de bande metallique
AU1690899A (en) Method for testing crohn's disease and testing kit therefor
HUP0003843A2 (en) Strip test for diagnosing allergies in-vitro
EP1125107A4 (fr) Epreuves permettant une evaluation rapide d'etats ischemiques et necessaires a cet effet
BR0014088A (pt) Contador de consumo para meios lìquidos e gasosos
AU8904598A (en) Methods, kits, electrodes and compositions for assessing the level of an analyteof interest in fluid samples
ATA109996A (de) Teststreifen für urinanalyten und teststreifen für urinanalyten und auswertefarbtafeln auswertefarbtafeln

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

PUAL Search report despatched

Free format text: ORIGINAL CODE: 0009013

AK Designated contracting states

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

RIC1 Information provided on ipc code assigned before grant

Free format text: 7G 01N 33/74 A, 7G 01N 33/58 B, 7G 01N 33/543 B, 7C 12Q 1/60 B, 7G 01N 33/92 B

AKX Designation fees paid
REG Reference to a national code

Ref country code: DE

Ref legal event code: 8566

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20010120